The Quantellect read.As of Nov 19, 2026, 5 active firms cover Tela Bio Inc: 4 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $1.00 to $3.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $2.00 sits 156% above the current $0.78. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.11 next quarter toward $-0.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy480%
Neutral120%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$2.00
+155.9% upside
Average target across 5 active firms as of Nov 19, 2026 vs $0.78 current
Highest Target$3.00
Average Target$2.00
Lowest Target$1.00
Detailed analyst forecasts for TELA
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 4 of 5 active firms rate TELA a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TELA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.11
Range $-0.12 – $-0.10 · 2 analysts
Next period, 2 analysts expect Tela Bio Inc to earn $-0.11 a share (range $-0.12 – $-0.10), versus — a year earlier. Full-year consensus is $-0.67, growing to $-0.48 the year after.
REVENUE · NEXT QUARTER
$20.0M
Range $19.4M – $21.3M · 2 analysts
Revenue is expected to reach $20.0M (range $19.4M – $21.3M). Full-year consensus is $76.5M, rising to $82.3M next year.
Top analysts covering Tela Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TELA.
#1
Chase Knickerbocker
Craig-Hallum · Rank #17
Buy
$2.00+155.9% to target
Overall win rate
61%
+ Follow
#2
CC
Caitlin Cronin
Canaccord Genuity · Rank #260
Buy
$4.00+411.8% to target
Overall win rate
39%
+ Follow
#3
David Turkaly
JMP Securities · Rank #453
Buy
$3.00+283.8% to target
Overall win rate
35%
+ Follow
#4
Frank Takkinen
Lake Street · Rank #514
Buy
$2.00+155.9% to target
Overall win rate
27%
+ Follow
#5
Matt O'Brien
Piper Sandler · Rank #561
Neutral
$1.00+27.9% to target
Overall win rate
25%
+ Follow
TELA stock forecast FAQ
What is TELA's average 12-month price target?+
The 5 active firms with a live target average $2.00 for Tela Bio Inc over the next 12 months, ranging from a $3.00 high to a $1.00 low, as of Nov 19, 2026.
Is TELA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for TELA?+
The Street-high target is $3.00 (Citizens), and the Street-low is $1.00 (Piper Sandler). The average of all 5 active-firm targets is $2.00.
How many active Wall Street firms cover TELA?+
5 active firms have a recognized rating on Tela Bio Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TELA?+
Among analysts who currently cover TELA, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #17). Their current call is Buy with a $2.00 target.
What is Tela Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.11 per share (range $-0.12 – $-0.10) across 2 analysts. Full-year EPS is projected at $-0.67, rising to $-0.48 the following year.
How much revenue is Tela Bio Inc expected to report next quarter?+
Consensus revenue is $20.0M (range $19.4M – $21.3M). Full-year revenue is projected at $76.5M, growing to $82.3M next year.
Have analysts been upgrading or downgrading TELA lately?+
As of Nov 19, 2026, 4 of 5 active firms rate TELA a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TELA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.